Clinical Trial

End-tidal Carbon Dioxide as a Non-invasive Predictor for Changes in Cardiac Output in Non-cardiac Surgery

Completed
View on ClinicalTrials.gov →
Summary
Cardiac output (CO) is challenging to measure at the bedside. The traditional gold standard for measuring CO requires the insertion of a pulmonary artery catheter which is invasive, associated with a risk for serious complications \[3\],with no clinical benefits. The cerebral blood flow (CBF) is considered to be a proportion of total cardiac output (CO). It has been stated earlier that approximately 15% of resting CO is distributed to the brain. Therefore, the flow through the CCA might serve as a surrogate parameter for CO.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-07.
Status change: Not Yet Recruiting → Completed 2026-03-10
Trial Details
NCT Number NCT06962748
Lead Sponsor Ain Shams University
Conditions Non Cardiac Surgery
Enrollment 105 participants
Start Date 2025-06-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-12